Evaluation of a CD13 and Integrin αvβ3 Dual-Receptor Targeted Tracer 68Ga-NGR-RGD for Ovarian Tumor Imaging: Comparison With 18F-FDG

Y Long, F Shao, H Ji, X Song, X Lv, X Xia, Q Liu… - Frontiers in …, 2022 - frontiersin.org
Ovarian cancer has the highest mortality rate of gynecologic malignancy. 18F-FDG positron
emission tomography (PET) adds an important superiority over traditional anatomic imaging …

Preclinical evaluation of a dual-receptor targeted tracer [68Ga]Ga-HX01 in 10 different subcutaneous and orthotopic tumor models

X Lv, X Song, Y Long, D Zeng, X Lan, Y Gai - European Journal of Nuclear …, 2023 - Springer
Purpose The integrin αvβ3 and aminopeptidase N (APN/CD13) play vital roles in the tumor
angiogenesis process. They are highly expressed in a variety of tumor cells and proliferating …

First-in-Human Study of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET for Integrin αvβ3 Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety …

MM Clausen, EA Carlsen, C Christensen, J Madsen… - Diagnostics, 2022 - mdpi.com
Arginine-Glycine-Aspartate (RGD)-recognizing cell surface integrins are involved in tumor
growth, invasiveness/metastases, and angiogenesis, and are therefore an attractive …

[HTML][HTML] Synthesis and evaluation of 68Ga-labeled dimeric cNGR peptide for PET imaging of CD13 expression with ovarian cancer xenograft

Y Yang, J Zhang, H Zou, Y Shen, S Deng… - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Introduction: Previous studies have shown that peptides containing the asparagine-glycine-
arginine (NGR) sequence can specifically bind to CD13 (aminopeptidase N) receptor, a …

18F labeled RGD‐A7R peptide for dual integrin and VEGF‐targeted tumor imaging in mice bearing U87MG tumors

Y Ma, S Liang, J Guo, R Guo… - Journal of Labelled …, 2014 - Wiley Online Library
The aim of this study is to develop a novel Arg‐Gly‐Asp acid (RGD) and Ala‐Thr‐Trp‐Leu‐
Pro‐Pro‐Arg (ATWLPPR A7R) peptide‐containing ligand for 18F labeling as αvβ3 and …

68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging

Z Liu, G Niu, J Shi, S Liu, F Wang, S Liu… - European journal of …, 2009 - Springer
Abstract Purpose Radiolabeled cyclic RGD (Arg-Gly-Asp) peptides have great potential for
the early tumor detection and noninvasive monitoring of tumor metastasis and therapeutic …

18F-RGD-K5: a cyclic triazole-bearing RGD peptide for imaging integrin αvβ3 expression in vivo

H Kolb, J Walsh, Q Liang, T Zhao, D Gao, J Secrest… - 2009 - Soc Nuclear Med
329 Objectives To identify and validate 18 F-RGD-K5, a click chemistry-derived RGD-
containing tracer for imaging integrin α v β 3 expression in vivo. Methods RGD-K5 binding …

Evaluation of an Integrin αvβ3 and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging

Y Gai, Y Jiang, Y Long, L Sun, Q Liu, C Qin… - Molecular …, 2019 - ACS Publications
Integrin αvβ3 and aminopeptidase N (APN, also known as CD13) are two important targets
involved in the regulation of angiogenesis, tumor proliferation, invasion, and metastasis. In …

Biodistribution and pharmacokinetics of the αvβ3-selective tracer 18F-galacto-RGD in cancer patients

AJ Beer, R Haubner, M Goebel… - Journal of nuclear …, 2005 - Soc Nuclear Med
18F-Galacto-RGD has been developed for PET of αvβ3 integrin expression, a receptor
involved in, for example, angiogenesis and metastasis. Our aim was to study the kinetics …

Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26 …

X Wen, R Wang, P Xu, M Shi, Q Shang, X Zeng… - European Journal of …, 2024 - Springer
Integrin receptor αvβ3 and gastrin-releasing peptide receptor (GRPR) expression of tumors
could be detected using PET imaging with radiolabeled Arg-Gly-Asp (RGD) and the …